1987年：稀释血液心脏停搏液的最大氧合。1994年更新。 - Suppr | 超能文献

1987: Maximal oxygenation of dilute blood cardioplegic solution. Updated in 1994.

作者信息

Hendren W G, O'Keefe D D, Geffin G A, Denenberg A G, Love T R, Daggett W M

机构信息

Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston 02114.

出版信息

Ann Thorac Surg. 1994 Nov;58(5):1558-9. doi: 10.1016/0003-4975(94)91965-8.

DOI:10.1016/0003-4975(94)91965-8

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

1987: Maximal oxygenation of dilute blood cardioplegic solution. Updated in 1994.1987年：稀释血液心脏停搏液的最大氧合。1994年更新。

Ann Thorac Surg. 1994 Nov;58(5):1558-9. doi: 10.1016/0003-4975(94)91965-8.

2

Studies of controlled reperfusion after ischemia. XIX. Reperfusate composition: benefits of blood cardioplegia over fluosol DA cardioplegia during regional reperfusion--importance of including blood components in the initial reperfusate.缺血后控制性再灌注的研究。第十九部分。再灌注液成分：在局部再灌注期间血液停搏液优于氟碳化合物DA停搏液的益处——初始再灌注液中包含血液成分的重要性。

J Thorac Cardiovasc Surg. 1991 Feb;101(2):284-93.

3

Oxygenation of cardioplegic solutions. Potential for the calcium paradox.心脏停搏液的氧合作用。钙反常的可能性。

J Thorac Cardiovasc Surg. 1987 Oct;94(4):614-25.

4

Studies of controlled reperfusion after ischemia. XXI. Reperfusate composition: superiority of blood cardioplegia over crystalloid cardioplegia in limiting reperfusion damage--importance of endogenous oxygen free radical scavengers in red blood cells.缺血后控制性再灌注的研究。XXI. 再灌注液成分：血液停搏液在限制再灌注损伤方面优于晶体停搏液——红细胞内源性氧自由基清除剂的重要性。

J Thorac Cardiovasc Surg. 1991 Feb;101(2):303-13.

5

Benefits of glucose and oxygen in multidose cold cardioplegia.

J Thorac Cardiovasc Surg. 1992 Feb;103(2):219-29.

6

Overdose reperfusion of blood cardioplegic solution. A preventable cause of postischemic myocardial depression.血液停搏液过量再灌注。缺血后心肌抑制的一个可预防原因。

J Thorac Cardiovasc Surg. 1991 Feb;101(2):275-83.

7

Studies of controlled reperfusion after ischemia. XX. Reperfusate composition: detrimental effects of initial asanguineous cardioplegic washout after acute coronary occlusion.

J Thorac Cardiovasc Surg. 1991 Feb;101(2):294-302.

8

Metabolic monitoring during continuous warm- and cold-blood cardioplegia by means of myocardial tissue pH and PO2.通过心肌组织pH值和PO2对持续冷血和温血心脏停搏期间进行代谢监测。

Can J Surg. 1998 Apr;41(2):142-8.

9

Custodiol-N, the novel cardioplegic solution reduces ischemia/reperfusion injury after cardiopulmonary bypass.新型心脏停搏液Custodiol-N可减轻体外循环后的缺血/再灌注损伤。

J Cardiothorac Surg. 2015 Feb 28;10:27. doi: 10.1186/s13019-015-0226-9.

10

The efficacy of blood cardioplegia is not due to oxygen delivery.冷血心脏停搏液的功效并非归因于氧输送。

J Thorac Cardiovasc Surg. 1989 Dec;98(6):1051-6.

引用本文的文献

1

"The non-ischemic repair" as a safe alternative method for repair of anterior post-infarction VSD.“非缺血性修复”作为心肌梗死后室间隔缺损前壁修复的一种安全替代方法。

J Cardiothorac Surg. 2010 Feb 19;5:6. doi: 10.1186/1749-8090-5-6.